News
Malvern, Purdue collaborate to advance nanotechnology
Malvern Instruments and Birck Nanotechnology Center at Purdue University have enterted into collaboration to examine the application of light scattering techniques in the characterization of nanoparticles and advance nanotechnology. The collaboration is formed for...
News
Harmonix introduces non-prescription sleep aid
Harmonix has introduced Sleep Formula 39 to overcome sleep problems and to provide a better night's sleep. Sleep Formula 39 is a non-prescription sleep aid made up with a proprietary combination of sleep ingredients...
News
CellCura partners IDT Biologika for protein free media
CellCura has entered into a memorandum of understanding with IDT Biologika to test and adapt its patented protein free media used in the production of human vaccine. The protein free media improves safety and stability in...
News
USP opens new testing facility in India
US Pharmacopeial Convention has opened a new expanded testing facility in the IKP Knowledge Park in Hyderabad, India. The new facility will allow voluntary testing and auditing program that helps dietary supplement manufacturers ensure and attest...
News
BioVigilant submits rapid biologic detection systems DMFs with FDA
BioVigilant has submitted Type V drug master files of IMD-A 300 series of rapid biologic detection systems to the US Federal Drug Administration.BioVigilant's IMD system is used to detect the presence of bacteria in the pharmaceutical manufacturing environments. ...
News
Mannatech adds vitamin D to omega-3 supplement
Mannatech, a developer and provider of nutritional supplements and skin care products based on Real Food Technology solutions, has added vitamin D to its omega-3 supplement. The new Omega-3 with Vitamin D3 capsules now comprise 830...
News
Isconova, Genocea widen licensing deal
Isconova and Genocea Biosciences have widened their existing agreement, under which Isconova has given license for using its Matrix M to Genocea Biosciences in vaccines targeting two additional diseases. Currently, Genocea has the right to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.